Centene Reports Strong Q2 2026 Results, Raises Full-Year Guidance…

Event summary

Centene reported Q2 2026 GAAP diluted EPS of $2.19, up from a loss of $0.51 in Q2 2025.
Total revenues increased by 4% to $53.6 billion, driven by premium yield and membership growth in the PDP business.
Health benefits ratio (HBR) improved to 89.6% from 93.0% year-over-year.
Centene raised its full-year 2026 GAAP diluted EPS guidance to greater than $3.11 and adjusted diluted EPS to greater than $4.80.

The big picture

Centene's strong Q2 2026 results reflect significant progress in restoring profitability, driven by improved pricing, risk transfer, and cost management. The company's strategic focus on Medicare Advantage and PDP businesses positions it well to capitalize on the growing demand for government-sponsored healthcare programs. However, Centene must navigate regulatory uncertainties and competitive pressures to sustain its momentum.

What we're watching

Profitability Trends: Whether Centene can sustain its improved HBR and cost management initiatives to maintain profitability.
Membership Dynamics: The pace at which Centene can grow membership in its Medicare and PDP businesses amid competitive pressures.
Regulatory Environment: How changes in CMS policies and state-directed payments may impact Centene's revenue and operational strategies.